Schrier Robert W, Brosnahan Godela, Cadnapaphornchai Melissa A, Chonchol Michel, Friend Keith, Gitomer Berenice, Rossetti Sandro
Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, Colorado; and
Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, Colorado; and.
J Am Soc Nephrol. 2014 Nov;25(11):2399-418. doi: 10.1681/ASN.2013111184. Epub 2014 Jun 12.
Autosomal dominant polycystic kidney disease is a genetic disorder associated with substantial variability in its natural course within and between affected families. Understanding predictors for rapid progression of this disease has become increasingly important with the emergence of potential new treatments. This systematic review of the literature since 1988 evaluates factors that may predict and/or effect autosomal dominant polycystic kidney disease progression. Predicting factors associated with early adverse structural and/or functional outcomes are considered. These factors include PKD1 mutation (particularly truncating mutation), men, early onset of hypertension, early and frequent gross hematuria, and among women, three or more pregnancies. Increases in total kidney volume and decreases in GFR and renal blood flow greater than expected for a given age also signify rapid disease progression. Concerning laboratory markers include overt proteinuria, macroalbuminuria, and perhaps, elevated serum copeptin levels in affected adults. These factors and others may help to identify patients with autosomal dominant polycystic kidney disease who are most likely to benefit from early intervention with novel treatments.
常染色体显性多囊肾病是一种遗传性疾病,在受影响的家族内部和家族之间,其自然病程存在很大差异。随着潜在新疗法的出现,了解该疾病快速进展的预测因素变得越来越重要。本对1988年以来文献的系统综述评估了可能预测和/或影响常染色体显性多囊肾病进展的因素。考虑了与早期不良结构和/或功能结局相关的预测因素。这些因素包括PKD1突变(特别是截短突变)、男性、高血压早发、早期频繁出现肉眼血尿,以及在女性中,三次或更多次怀孕。在特定年龄下,总肾体积增加、肾小球滤过率和肾血流量下降超过预期也表明疾病进展迅速。相关的实验室指标包括显性蛋白尿、大量白蛋白尿,或许还有受影响成年人血清 copeptin 水平升高。这些因素及其他因素可能有助于识别最有可能从新型疗法早期干预中获益的常染色体显性多囊肾病患者。